Nordhealth AS (NORDH) — Capital Reinvestment Ratio

Latest as of September 2025: 3.10x

Nordhealth AS (NORDH) has a Capital Reinvestment Ratio of 3.10x as of September 2025, meaning it reinvests 3% of its operating cash flow (Nkr1.22 Million) in capital expenditures (Nkr3.77 Million). Check NORDH goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

3.10x
Capex / Operating Cash Flow

Operating Cash Flow

Nkr1.22 Million
NOK

Capital Expenditures

Nkr3.77 Million
NOK

Data as of

Sep 2025
Most recent filing

Nordhealth AS Capital Reinvestment Ratio (2018–2025)

This chart tracks Nordhealth AS's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see NORDH operating cash flow.

Annual Capital Reinvestment Ratio for Nordhealth AS (2018–2025)

Year-by-year Capital Reinvestment Ratio for Nordhealth AS from 2018 to 2025. See how much free cash does Nordhealth AS generate to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (NOK) Capital Expenditures YoY Change
2025 7.08x Nkr719.00K Nkr5.09 Million ▲ +160.8%
2024 2.72x Nkr1.85 Million Nkr5.02 Million ▲ +347.8%
2021 0.61x Nkr5.57 Million Nkr3.38 Million ▲ +0.0%
2020 0.61x Nkr5.57 Million Nkr3.38 Million ▲ +0.0%
2019 0.61x Nkr5.57 Million Nkr3.38 Million ▲ +0.0%
2018 0.61x Nkr5.57 Million Nkr3.38 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow